Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
P106883-5g | 5g | In stock | $10.90 | |
P106883-10g | 10g | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $16.90 | |
P106883-25g | 25g | In stock | $31.90 | |
P106883-100g | 100g | In stock | $112.90 | |
P106883-500g | 500g | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $304.90 |
Synonyms | Pyrazine-2-carboxylic acid | 2-Pyrazinecarboxylic acid | 98-97-5 | pyrazinoic acid | pyrazinecarboxylic acid | Pyrazinic acid | Paradiazinecarboxylic acid | pyrazinemonocarboxylic acid | 2-Carboxypyrazine | 2-Pyrazine carboxylic acid | 2-Pyrazinoic acid | Piazinecarboxylic aci |
---|---|
Specifications & Purity | ≥98% |
Shipped In | Normal |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Pubchem Sid | 488179593 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488179593 |
IUPAC Name | pyrazine-2-carboxylic acid |
INCHI | InChI=1S/C5H4N2O2/c8-5(9)4-3-6-1-2-7-4/h1-3H,(H,8,9) |
InChi Key | NIPZZXUFJPQHNH-UHFFFAOYSA-N |
Canonical SMILES | C1=CN=C(C=N1)C(=O)O |
Isomeric SMILES | C1=CN=C(C=N1)C(=O)O |
WGK Germany | 3 |
PubChem CID | 1047 |
Molecular Weight | 124.1 |
Beilstein | 112305 |
Reaxy-Rn | 112305 |
Enter Lot Number to search for COA:
Solubility | Solubility in hot Water:almost transparency |
---|---|
Melt Point(°C) | 222-225°C |
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation H302:Harmful if swallowed |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P271:Use only outdoors or in a well-ventilated area. P270:Do not eat, drink or smoke when using this product. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P403+P233:Store in a well-ventilated place. Keep container tightly closed. P362+P364:Take off contaminated clothing and wash it before reuse. P330:Rinse mouth. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P301+P317:IF SWALLOWED: Get medical help. P337+P317:If eye irritation persists: Get medical help. P332+P317:If skin irritation occurs: Get medical help. P319:Get medical help if you feel unwell. |
WGK Germany | 3 |
Reaxy-Rn | 112305 |
Merck Index | 8970 |
1. Groll M, Berkers CR, Ploegh HL, Ovaa H. (2006) Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome.. Structure, 14 (3): (451-6). [PMID:16531229] |
2. Mary Margaret Wade,Ying Zhang. (2004-07-24) Anaerobic incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis.. Journal of medical microbiology, 53 ((Pt 8)): (769-773). [PMID:15272064] |
3. Takashi Iwanaga,Masanobu Sato,Tomoji Maeda,Toshio Ogihara,Ikumi Tamai. (2006-10-18) Concentration-dependent mode of interaction of angiotensin II receptor blockers with uric acid transporter.. The Journal of pharmacology and experimental therapeutics, 320 ((1)): (211-217). [PMID:17043154] |
4. Oren Zimhony,Catherine Vilchèze,Masayoshi Arai,John T Welch,William R Jacobs. (2006-11-15) Pyrazinoic acid and its n-propyl ester inhibit fatty acid synthase type I in replicating tubercle bacilli.. Antimicrobial agents and chemotherapy, 51 ((2)): (752-754). [PMID:17101678] |
5. Silvana C Ngo,Oren Zimhony,Woo Jin Chung,Halimah Sayahi,William R Jacobs,John T Welch. (2007-05-09) Inhibition of isolated Mycobacterium tuberculosis fatty acid synthase I by pyrazinamide analogs.. Antimicrobial agents and chemotherapy, 51 ((7)): (2430-2435). [PMID:17485499] |
6. Bruce A Ellsworth,Ying Wang,Yeheng Zhu,Annapurna Pendri,Samuel W Gerritz,Chongqing Sun,Kenneth E Carlson,Liya Kang,Rose A Baska,Yifan Yang,Qi Huang,Neil T Burford,Mary Jane Cullen,Susan Johnghar,Kamelia Behnia,Mary Ann Pelleymounter,William N Washburn,William R Ewing. (2007-05-22) Discovery of pyrazine carboxamide CB1 antagonists: the introduction of a hydroxyl group improves the pharmaceutical properties and in vivo efficacy of the series.. Bioorganic & medicinal chemistry letters, 17 ((14)): (3978-3982). [PMID:17513109] |
7. Tawfik Gharbaoui,Philip J Skinner,Young-Jun Shin,Claudia Averbuj,Jae-Kyu Jung,Benjamin R Johnson,Tracy Duong,Marc Decaire,Jane Uy,Martin C Cherrier,Peter J Webb,Susan Y Tamura,Ning Zou,Nathalie Rodriguez,P Douglas Boatman,Carleton R Sage,Andrew Lindstrom,Jerry Xu,Thomas O Schrader,Brian M Smith,Ruoping Chen,Jeremy G Richman,Daniel T Connolly,Steven L Colletti,James R Tata,Graeme Semple. (2007-06-26) Agonist lead identification for the high affinity niacin receptor GPR109a.. Bioorganic & medicinal chemistry letters, 17 ((17)): (4914-4919). [PMID:17588745] |
8. Stefania Tanase,Patricia Marques-Gallego,Wesley R Browne,Ronald Hage,Elisabeth Bouwman,Ben L Feringa,Jan Reedijk. (2008-04-03) Mechanistic implications of the active species involved in the oxidation of hydrocarbons by iron complexes of pyrazine-2-carboxylic acid.. Dalton transactions (Cambridge, England : 2003), ((15)(15)): (2026-2033). [PMID:18382780] |
9. Keisuke Kagami,Kenji Onda,Kitaro Oka,Toshihiko Hirano. (2008-07-01) Suppression of blood lipid concentrations by volatile Maillard reaction products.. Nutrition (Burbank, Los Angeles County, Calif.), 24 ((11-12)): (1159-1166). [PMID:18586457] |
10. Wolfgang Holzer,Gernot A Eller,Barbara Datterl,Daniela Habicht. (2009-04-30) Derivatives of pyrazinecarboxylic acid: 1H, 13C and 15N NMR spectroscopic investigations.. Magnetic resonance in chemistry : MRC, 47 ((7)): (617-624). [PMID:19402051] |
11. Marta Filipa Simões,Emília Valente,M José Rodríguez Gómez,Elsa Anes,Luís Constantino. (2009-06-06) Lipophilic pyrazinoic acid amide and ester prodrugs stability, activation and activity against M. tuberculosis.. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 37 ((3-4)): (257-263). [PMID:19491013] |
12. João P S Fernandes,Kerly F M Pasqualoto,Veni M A Felli,Elizabeth I Ferreira,Carlos A Brandt. (2010-01-26) QSAR modeling of a set of pyrazinoate esters as antituberculosis prodrugs.. Archiv der Pharmazie, 343 ((2)): (91-97). [PMID:20099263] |
13. Anthony D Baughn,Jiaoyu Deng,Catherine Vilchèze,Angelica Riestra,John T Welch,William R Jacobs,Oren Zimhony. (2010-09-30) Mutually exclusive genotypes for pyrazinamide and 5-chloropyrazinamide resistance reveal a potential resistance-proofing strategy.. Antimicrobial agents and chemotherapy, 54 ((12)): (5323-5328). [PMID:20876380] |
14. Ping Lu,Anna C Haagsma,Hoang Pham,Janneke J Maaskant,Selena Mol,Holger Lill,Dirk Bald. (2011-08-31) Pyrazinoic acid decreases the proton motive force, respiratory ATP synthesis activity, and cellular ATP levels.. Antimicrobial agents and chemotherapy, 55 ((11)): (5354-5357). [PMID:21876062] |
15. Stewart T Cole. (2011-09-17) Microbiology. Pyrazinamide--old TB drug finds new target.. Science (New York, N.Y.), 333 ((6049)): (1583-1584). [PMID:21921185] |
16. Martin Dolezal,Diana Kesetovic,Jan Zitko. (2011-11-15) Antimycobacterial evaluation of pyrazinoic acid reversible derivatives.. Current pharmaceutical design, 17 ((32)): (3506-3514). [PMID:22074423] |
17. Mirko Zimic,Sebastian Loli,Robert H Gilman,Andrés Gutierrez,Patricia Fuentes,Milagros Cotrina,Daniela Kirwan,Patricia Sheen. (2012-03-01) A new approach for pyrazinamide susceptibility testing in Mycobacterium tuberculosis.. Microbial drug resistance (Larchmont, N.Y.), 18 ((4)): (372-375). [PMID:22372927] |
18. Hyun Kim,Keigo Shibayama,Emiko Rimbara,Shigetarou Mori. (2014-06-21) Biochemical characterization of quinolinic acid phosphoribosyltransferase from Mycobacterium tuberculosis H37Rv and inhibition of its activity by pyrazinamide.. PloS one, 9 ((6)): (e100062-e100062). [PMID:24949952] |
19. W Ebeid,M Salim,E Elkady,A Elzahr,R El-Bagary,G Patonay. (2015-07-21) Simultaneous determination of valsartan, amlodipine besylate and hydrochlorothiazide using capillary zone electrophoresis (CZE).. Die Pharmazie, 70 ((6)): (368-373). [PMID:26189296] |
20. Beatriz E Bolívar,John T Welch. (2017-02-22) Studies of the Binding of Modest Modulators of the Human Enzyme, Sirtuin\u20056, by STD NMR.. Chembiochem : a European journal of chemical biology, 18 ((10)): (931-940). [PMID:28222243] |
21. Shirou Itagaki,Soji Shimamoto,Mitsuru Sugawara,Michiya Kobayashi,Katsumi Miyazaki,Takeshi Hirano,Ken Iseki. (2005-08-09) Phenolsulfonphthalein transport by potential-sensitive urate transport system.. European journal of pharmacology, 518 ((2-3)): (83-89). [PMID:16083873] |
22. Rustam Z Khaliullin,Alexis T Bell,Martin Head-Gordon. (2006-07-21) A density functional theory study of the mechanism of free radical generation in the system vanadate/PCA/H2O2.. The journal of physical chemistry. B, 109 ((38)): (17984-17992). [PMID:16853308] |
23. Jhy-Wen Wu,Tung-Hu Tsai. (2007-06-02) Effect of silibinin on the pharmacokinetics of pyrazinamide and pyrazinoic acid in rats.. Drug metabolism and disposition: the biological fate of chemicals, 35 ((9)): (1603-1610). [PMID:17540707] |
24. Y Sheeena Mary,Hema Tresa Varghese,C Yohannan Panicker,Martin Dolezal. (2008-03-21) Vibrational spectroscopic studies and ab initio calculations of a substituted amide of pyrazine-2-carboxylic acid--C12H10ClN3O.. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 71 ((2)): (725-730). [PMID:18353710] |
25. Michael J Munchhof,Amy S Antipas,Laura C Blumberg,William H Brissette,Matthew F Brown,Jeffrey M Casavant,Jonathan L Doty,James Driscoll,Thomas M Harris,Lilli A Wolf-Gouveia,Christopher S Jones,Qifang Li,Robert G Linde,Paul D Lira,Anthony Marfat,Eric McElroy,Mark Mitton-Fry,Sandra P McCurdy,Lawrence A Reiter,Sharon L Ripp,Andrei Shavnya,Lisa M Thomasco,Kristen A Trevena. (2009-02-03) The identification of orally bioavailable thrombopoietin agonists.. Bioorganic & medicinal chemistry letters, 19 ((5)): (1428-1430). [PMID:19186055] |
26. Iwao Akashi,Keisuke Kagami,Toshihiko Hirano,Kitaro Oka. (2009-03-21) Protective effects of coffee-derived compounds on lipopolysaccharide/D-galactosamine induced acute liver injury in rats.. The Journal of pharmacy and pharmacology, 61 ((4)): (473-478). [PMID:19298694] |
27. Mohamed Abdel-Aziz,Hamdy M Abdel-Rahman. (2010-05-22) Synthesis and anti-mycobacterial evaluation of some pyrazine-2-carboxylic acid hydrazide derivatives.. European journal of medicinal chemistry, 45 ((8)): (3384-3388). [PMID:20488590] |
28. Masanobu Sato,Tomohiko Wakayama,Hideaki Mamada,Yoshiyuki Shirasaka,Takeo Nakanishi,Ikumi Tamai. (2010-11-16) Identification and functional characterization of uric acid transporter Urat1 (Slc22a12) in rats.. Biochimica et biophysica acta, 1808 ((6)): (1441-1447). [PMID:21074513] |
29. Halimah Sayahi,Oren Zimhony,William R Jacobs,Alexander Shekhtman,John T Welch. (2011-07-22) Pyrazinamide, but not pyrazinoic acid, is a competitive inhibitor of NADPH binding to Mycobacterium tuberculosis fatty acid synthase I.. Bioorganic & medicinal chemistry letters, 21 ((16)): (4804-4807). [PMID:21775138] |
30. Mirko Zimic,Patricia Fuentes,Robert H Gilman,Andrés H Gutiérrez,Daniela Kirwan,Patricia Sheen. (2011-10-19) Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance.. Tuberculosis (Edinburgh, Scotland), 92 ((1)): (84-91). [PMID:22004792] |
31. H J Kim,H K Kwak,J Lee,Y J Yun,J S Lee,M S Lee,S Y Min,S K Park,H S Kang,Y H Maeng,S Y Kim,S Y Kim,Y H Kook,Y R Kim,K H Lee. (2012-01-13) Patterns of pncA mutations in drug-resistant Mycobacterium tuberculosis isolated from patients in South Korea.. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 16 ((1)): (98-103). [PMID:22236853] |